Publication of Scheme Document.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

FOR IMMEDIATE RELEASE

29 August 2025

RECOMMENDED ACQUISITION

of

Epwin Group plc ("Epwin")

by

Laumann Group UK Limited ("Laumann UK")
(a wholly-owned indirect subsidiary of Laumann Stiftung & Co. KG ("Laumann"))
to be implemented by means of a scheme of arrangement
pursuant to Part 26 of the Companies Act 2006

PUBLICATION OF SCHEME DOCUMENT

On 7 August 2025, the Epwin Board and the Laumann UK Board announced that they had reached agreement on the terms and conditions of a recommended cash acquisition pursuant to which Laumann UK shall acquire the entire issued and to be issued ordinary share capital of Epwin (the "Acquisition"). The Acquisition is to be implemented by means of a Court-sanctioned scheme of arrangement pursuant to Part 26 of the Companies Act (the "Scheme").

Publication of the Scheme Document

Epwin is pleased to announce the publication of the scheme document in relation to the Scheme (the "Scheme Document") which, together with the associated Forms of Proxy, is today being published by Epwin and posted (or made available online) to Epwin Shareholders.

The Scheme Document will be made available (subject to any applicable restrictions relating to persons in, or resident, in Restricted Jurisdictions) for inspection free of charge, on Epwin's website at https://investors.epwin.co.uk/announcement-offer.aspx and on Laumann's website at https://www.laumann-group.com not later than 12.00 noon on 1 September 2025 and will continue to be made available on those websites during the offer period.

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Scheme Document. All references to times in this announcement are to London, United Kingdom time unless otherwise stated.

Notices of the Court Meeting and the General Meeting

The Court Meeting and the General Meeting are to be held at the offices of Eversheds Sutherland (International) LLP, 1 Wood Street, London EC2V 7WS, United Kingdom on 25 September 2025. The Court Meeting is scheduled to commence at 11.00 a.m. and the General Meeting is scheduled to commence at 11.15 a.m. (or as soon thereafter as the Court Meeting has concluded or been adjourned). Notices of the Court Meeting and the General Meeting are set out in Parts VIII and IX, respectively, of the Scheme Document.

As further described in the Scheme Document, before the Court is asked to sanction the Scheme and in order for it to become Effective, the Scheme will require: (i) the approval of a majority in number representing 75 per cent. or more in value of votes cast by the Scheme Shareholders present or represented and voting, either in person or by proxy, at the Court Meeting (or at any adjournment thereof); and (ii) the passing of the Special Resolution by the requisite majority of Epwin Shareholders at the General Meeting (or at any adjournment thereof). The Scheme is also subject to the satisfaction or (where applicable) waiver of the Conditions and further terms that are set out in the Scheme Document.

Any changes to the arrangements for the Court Meeting and the General Meeting will be communicated to the Scheme Shareholders and the Epwin Shareholders before the relevant Meetings, by an announcement through a Regulatory Information Service.

Action required

It is important that, for the Court Meeting in particular, as many votes as possible are cast (whether in person or by proxy) in order for the Court to be satisfied that there is a fair and reasonable representation of Scheme Shareholders' opinion. Therefore, whether or not Epwin Shareholders intend to attend the Meetings, Epwin Shareholders are strongly urged to appoint a proxy in connection with the Meetings in accordance with the instructions below and as set out in more detail in the Scheme Document.

Epwin Shareholders are strongly urged to complete, sign and return their Forms of Proxy or to appoint a proxy electronically either through Proxymity or through CREST (instructions to do so can be found in the CREST Manual) as soon as possible and, in any event, by no later than 11.00 a.m. on 23 September 2025 in respect of the Court Meeting and 11.15 a.m. on 23 September 2025 in respect of the General Meeting (or in the case of adjournment(s), not later than 48 hours before the time fixed for the adjourned meeting(s)) (excluding any part of such 48 hour period falling on a day which is not a Business Day) in accordance with the instructions set out in the Scheme Document and the Forms of Proxy. Instructions in relation to voting and the completion of the Forms of Proxy are included in the Scheme Document. Scheme Shareholders and Epwin Shareholders are also strongly encouraged to appoint "the Chair of the Meeting" as their proxy.

Recommendation

The Epwin Directors, who have been so advised by Shore Capital as to the financial terms of the Acquisition, unanimously consider the terms of the Acquisition to be fair and reasonable. In providing its advice to the Epwin Directors, Shore Capital has taken into consideration the commercial assessments of the Epwin Directors. Shore Capital is providing independent financial advice to the Epwin Directors for the purposes of Rule 3 of the Takeover Code.

The Epwin Directors consider the terms of the Acquisition to be in the best interests of Epwin Shareholders as a whole and, and accordingly, the Epwin Directors unanimously recommend that Scheme Shareholders vote in favour (or procure votes in favour) of the Scheme at the Court Meeting and that all Epwin Shareholders vote in favour (or procure votes in favour) of the Special Resolution at the General Meeting as the Epwin Directors have irrevocably undertaken to do (or, as may be applicable, procure to be done) in respect of their own beneficial holdings of 815,576 Epwin Shares representing, in aggregate, approximately 0.6 per cent. of the entire existing issued share capital of Epwin as at the Latest Practicable Date.

Epwin Shareholders should read carefully the whole of the Scheme Document (including any documents incorporated into the Scheme Document by reference), together with the accompanying Forms of Proxy, before deciding whether or not to vote, or procure a vote, in favour of the Scheme at the Court Meeting and the Special Resolution at the General Meeting. Each of these documents contains important information relating to the Acquisition. Any vote or decision in respect of, or other response to, the Acquisition or the Scheme (as applicable) should only be made on the basis of the information contained in the Scheme Document.

Irrevocable undertakings and letter of intent

Laumann UK has received irrevocable undertakings from each of the Epwin Directors who hold Epwin Shares to vote (or procure the vote) in favour of the Scheme at the Court Meeting and the Special Resolution to be proposed at the General Meeting, in respect of their beneficial interests in Epwin Shares (and those of certain connected persons) amounting, in aggregate, to 815,576 Epwin Shares, representing approximately 0.6 per cent. of the entire existing issued share capital of Epwin as at the Latest Practicable Date. All of these undertakings remain binding, even in the event of a higher competing offer for Epwin, unless the Scheme lapses or is withdrawn.

In addition, Laumann UK has received irrevocable undertakings to vote (or procure the vote) in favour of the Scheme at the Court Meeting and the Special Resolution to be proposed at the General Meeting from Kennedy Capital Investments Limited, the trustees of The Anthony James Rawson Business Will Trust and Pentwin Group Limited in respect of a total of 40,500,000 Epwin Shares, representing, in aggregate, approximately 29.8 per cent. of the entire existing issued share capital of Epwin as at the Latest Practicable Date. These irrevocable undertakings also include the relevant Epwin Shareholders' commitments to accept the Offer if the Acquisition is structured as an Offer. All of these undertakings remain binding, even in the event of a higher competing offer for Epwin, unless the Scheme lapses or is withdrawn.

Laumann UK has also received a letter of intent to vote (or procure the vote) in favour of the Scheme at the Court Meeting and the Special Resolution to be proposed at the General Meeting from Otus Capital Management Limited in respect of 5,033,594 Epwin Shares representing approximately 3.7 per cent. of the entire existing issued share capital of Epwin as at the Latest Practicable Date.

Laumann UK has therefore received irrevocable undertakings or letters of intent in respect of a total of 46,349,170 Epwin Shares representing, in aggregate, approximately 34.1 per cent. of the entire existing issued share capital of Epwin as at the Latest Practicable Date.

Full details of these irrevocable undertakings and letters of intent, including the circumstances in which such irrevocable undertakings cease to binding, are set out in the Scheme Document.

Expected timetable of principal events

An expected timetable of principal events for the Scheme is set out in the Scheme Document and is also reproduced in the appendix to this announcement. Subject to the requisite approval of Scheme Shareholders at the Court Meeting and of Epwin Shareholders at the General Meeting, the satisfaction or waiver (if capable of waiver) of the other Conditions set out in the Scheme Document and the sanction of the Scheme by the Court at the Sanction Hearing, the Scheme is currently expected to become Effective during the final quarter of 2025.

The dates and times given are indicative only and are based on Epwin's and Laumann UK's current expectations and may be subject to change. If any of the expected dates and/or times set out in the expected timetable change, then Epwin will give adequate notice(s) of such changes in an announcement released through a Regulatory Information Service and by making such announcement available on Epwin's website at https://investors.epwin.co.uk/announcement-offer.aspx.

Prior to the Scheme becoming Effective, Epwin shall make an application for the cancellation of trading of the Epwin Shares on AIM to take effect shortly after the Acquisition becomes Effective.

The last day of dealings in Epwin Shares on AIM is expected to be the Business Day immediately prior to the Effective Date and no transfers of Epwin Shares shall be registered after 6.00 p.m. on that date.

Helpline

If you have any questions about this announcement, the Scheme Document, the Court Meeting or the General Meeting, or are in any doubt as to how to complete and return the Forms of Proxy, please contact Epwin's registrar, MUFG Corporate Markets by calling on +44 (0) 371 664 0321, between 9.00 a.m. and 5.30 p.m. Monday to Friday (excluding public holidays in England and Wales). Alternatively, you can email MUFG Corporate Markets at shareholderenquiries@cm.mpms.mufg.com.

Epwin Share Plan proposals

Epwin Share Plan Participants have today been sent letters which contain details regarding the effect of the Scheme on Epwin Share Plan Participants' rights and the proposals being made in accordance with Rule 15 of the Takeover Code.

Enquiries:

Osborne Clarke LLP is retained as legal adviser to Laumann UK and Laumann.

Eversheds Sutherland (International) LLP is retained as legal adviser to Epwin. 

APPENDIX

Expected timetable of principal events

All dates and times are based on Epwin's and Laumann UK's current expectations and are subject to change. If any of the dates and/or times in this expected timetable change, the revised dates and/or times will be notified to Epwin Shareholders by announcement through a Regulatory Information Service and by posting notice of these dates on the following website: https://investors.epwin.co.uk/announcement-offer.aspx.

Important notices

You should read this announcement and the Scheme Document and if you are in any doubt as to the Acquisition or the action you should take, you are recommended to seek your own personal financial, tax and legal advice immediately from your stockbroker, solicitor, accountant, bank manager or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if you are not so resident, from another appropriately authorised independent financial adviser. If you have any questions about the Scheme Document, the Court Meeting or the General Meeting or are in any doubt as to how to complete the Forms of Proxy, please contact MUFG Corporate Markets on the number set out above.

This announcement, the Scheme Document and any of the accompanying documents to the Scheme Document do not, nor are they intended to, constitute or form part of an offer or an invitation to purchase or subscribe for any securities, or a solicitation of an offer to buy any securities, whether pursuant to this announcement or otherwise, in any jurisdiction in which such offer, invitation or solicitation is or would be unlawful.

This announcement does not comprise a prospectus or a prospectus equivalent document or an exempted document.

The contents of this announcement do not amount to, and should not be construed as, legal, tax, business or financial advice.

The statements contained in this announcement are made as at the date of this announcement, unless some other date is specified in relation to them, and publication of this announcement shall not give rise to any implication that there has been no change in the facts set forth in this announcement since such date.

The Scheme Document has been prepared for the purposes of complying with English law, the jurisdiction of the Court and the applicable requirements of the Takeover Code, the Market Abuse Regulation, the Disclosure Guidance and Transparency Rules and the AIM Rules.

Houlihan Lokey UK Limited ("Houlihan Lokey"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA"), is acting exclusively for Laumann UK and Laumann and no one else in connection with the Acquisition and will not be responsible to anyone other than Laumann UK and Laumann for providing the protections afforded to clients of Houlihan Lokey, nor for providing advice in relation to the Acquisition or any matter or arrangement referred to herein. Neither Houlihan Lokey nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Houlihan Lokey in connection with this announcement, any statement contained herein or otherwise.

Shore Capital and Corporate Limited and Shore Capital Stockbrokers Limited (either individually or collectively "Shore Capital"), which are authorised and regulated by the FCA in the United Kingdom, are acting exclusively for Epwin and no one else in connection with the Acquisition and/or any other matter referred to in this announcement and will not regard any other person as their client in relation to such matters and will not be responsible to anyone other than Epwin for providing the protections afforded to clients of Shore Capital nor for providing advice in relation to the Acquisition, the contents of this announcement, or any other matter, transaction or arrangement referred to in this announcement. Neither Shore Capital and Corporate Limited nor Shore Capital Stockbrokers Limited, nor  any  of their subsidiaries, branches or  affiliates  owes  or  accepts  any  duty,  liability  or  responsibility  whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to  any  person  who  is  not  a  client  of Shore Capital in  connection  with  this  announcement,  any  statement contained herein, any transaction or arrangement referred to herein, or otherwise.

Overseas Shareholders

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and/or regulations. No action has been taken by Epwin, Laumann or Laumann UK to obtain any approval, authorisation or exemption to permit the possession or distribution of this announcement in any jurisdiction, other than the United Kingdom.

Unless otherwise determined by Laumann UK or Laumann or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from or by use of the mails or any other means or instrumentality (including, without limitation, telephonic or electronic) of interstate or foreign commerce of, or any facility of a national, state or other securities exchange of, a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and no person may vote in favour of the Acquisition by any such use, means, instrumentality or facility or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this announcement and all documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and persons receiving this announcement and all documentation relating to the Acquisition (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from such jurisdictions where to do so would violate the laws in those jurisdictions. If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), such Takeover Offer may not be made available directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction.

The availability of the Acquisition to Epwin Shareholders who are not resident in the United Kingdom (and, in particular, their ability to vote their Scheme Shares with respect to the Scheme at the Court Meeting, or to appoint another person as proxy to vote at the Court Meeting on their behalf) may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements, as any failure to comply with such requirements may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. The Acquisition is subject to the applicable requirements of the Takeover Code, the Panel, the London Stock Exchange, the Financial Conduct Authority and the AIM Rules.

This announcement does not constitute a prospectus or prospectus exempted document. The statements contained in this announcement are not to be construed as legal, business, financial or tax advice.

Additional Information for US Investors

The Acquisition relates to the securities of an English company by means of a scheme of arrangement provided for under the laws of England and Wales.

A transaction effected by means of a scheme of arrangement is not subject to shareholder vote, proxy solicitation or tender offer rules under the US Exchange Act or other requirements of US law. Instead, the Scheme will be subject to the disclosure requirements and practices applicable in the UK to schemes of arrangement, which differ from the disclosure requirements and practices of the US under the US Exchange Act. The financial information included in the Scheme Document (or, if the Acquisition is to be implemented by way of a Takeover Offer, the documents to be sent to Epwin Shareholders which will contain the terms and conditions of such Takeover Offer) has been or will have been prepared in accordance with accounting standards applicable in the UK and thus may not be comparable to the financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the US. Generally accepted accounting principles in the US differ in significant respects from accounting standard applications in the United Kingdom.

If Laumann UK were to elect to implement the Acquisition by means of a Takeover Offer and determined to extend such Takeover Offer into the United States, such Takeover Offer would be made in compliance with all applicable US laws and regulations, including to the extent applicable Section 14(e) of the US Exchange Act and Regulation 14E thereunder, and in accordance with the Takeover Code. Such a takeover would be made in the United States by Laumann UK and no one else.

The receipt of cash pursuant to the Acquisition by a US holder of Epwin Shares as consideration for the transfer of its Scheme Shares pursuant to the Scheme will likely be a taxable transaction for US federal income tax purposes and under applicable US state and local, as well as foreign and other, tax laws. Each such Epwin Shareholder is urged to consult their independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him or her. Accordingly, the Acquisition would be subject to disclosure and other procedural requirements, including with respect to withdrawal rights, offer timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer procedures and law.

It may be difficult for US holders of Epwin Shares to enforce their rights and any claim arising out of the US federal securities laws, since Epwin is located in a non-US jurisdiction, and some or all of the Epwin Directors may be residents of a non-US jurisdiction. US holders of Epwin Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgment.

In accordance with normal UK practice and consistent with Rule 14e-5(b) under the US Exchange Act, Laumann UK, certain affiliated companies and their nominees or brokers (acting as agents) may make certain purchases of, or arrangements to purchase, shares in Epwin outside of the US, other than pursuant to the Acquisition, until the date on which the Acquisition and/or Scheme becomes Effective, lapses or is otherwise withdrawn. If such purchases or arrangements to purchase were to be made, they would occur either in the open market at prevailing prices or in private transactions at negotiated prices and comply with applicable law, including to the extent applicable the US Exchange Act. Any information about such purchases or arrangements to purchase will be disclosed as required in the UK, will be reported to the Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com.

In accordance with the Takeover Code, normal United Kingdom market practice and Rule 14e-5(b) of the US Exchange Act, Shore Capital and its affiliates will continue to act as an exempt principal trader in Epwin securities on the London Stock Exchange. These purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Takeover Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com.

Neither the US Securities and Exchange Commission, nor any US state securities commission or any securities commission of other jurisdictions, has approved or disapproved the Acquisition, passed judgement upon the fairness or the merits of the Acquisition, or passed judgement upon the adequacy or accuracy of this announcement or the Scheme Document. Any representation to the contrary may be a criminal offence in the United States.

Forward-looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Acquisition, and other information published by Laumann UK, Laumann and Epwin contain certain statements, beliefs or opinions, which are, or may be deemed to be, forward looking statements with respect to the financial condition, results of operations and business of Laumann UK, Laumann and Epwin or the Epwin Group. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "envisage", "estimate", "intend", "plan", "goal", "believe", "hope", "aims", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. These statements are based on assumptions and assessments made by Epwin, and/or Laumann UK and Laumann, in light of their experience and their perception of historical trends, current conditions, future developments and other factors they believe appropriate. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given by Laumann UK, Laumann and Epwin that such expectations will prove to have been correct and you are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Neither Epwin nor Laumann UK and Laumann assumes any obligation and Laumann UK, Laumann and Epwin disclaim any intention or obligation, to update or correct the information contained in this announcement (whether as a result of new information, future events or otherwise), except as required by applicable law or regulation (including under the AIM Rules and the Disclosure Guidance and Transparency Rules of the FCA).

No profit forecasts or estimates or Quantified Financial Benefits Statements

No statement in this announcement is intended as a profit forecast, profit estimate or quantified benefits statement for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Laumann UK and/or Epwin, as appropriate, for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Laumann UK and/or Epwin, as appropriate.

Dealing and Opening Position Disclosure Requirements of the Takeover Code

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th Business Day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the Business Day  following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Capitalised terms are defined in the Takeover Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to make a disclosure under Rule 8, you should consult the Panel.

 Publication on website

A copy of this announcement and the documents required to be published by Rule 26 of the Takeover Code will be made available (subject to certain restrictions relating to persons resident in Restricted Jurisdictions), free of charge, on Epwin's website at https://investors.epwin.co.uk/announcement-offer.aspx and on Laumann's website at https://www.laumann-group.com by no later than 12.00 noon on 1 September 2025. Neither the contents of these websites nor the content of any other website accessible from hyperlinks on such websites is incorporated into, or forms part of, this announcement.

Availability of hard copies

Pursuant to Rule 30.3 of the Takeover Code, a person so entitled may request a copy of the Scheme Document and any information incorporated into it by reference to another source in hard copy form. A person may also request that all future documents, announcements and information to be sent to that person in relation to the Acquisition should be in hard copy form. For persons who have received a copy of the Scheme Document in electronic form or via a website notification, a hard copy of the Scheme Document will not be sent unless so requested by contacting the Registrar of Epwin, MUFG Corporate Markets.

You may request a hard copy of this announcement, and all future documents, announcements and information in relation to the Acquisition, by writing to MUFG Corporate Markets, Corporate Actions, Central Square, 29 Wellington Street, Leeds LS1 4DL United Kingdom or by calling between 9.00 a.m. and 5.30 p.m. on Monday to Friday (excluding public holidays in England and Wales) on +44 (0) 371 664 0321. Calls to this number are charged at the standard geographic rate and will vary by provider or, in the case of calls from outside the UK, at the applicable international rate. Calls from a mobile device may incur network extras. Alternatively, you can email MUFG Corporate Markets at shareholderenquiries@cm.mpms.mufg.com. Please note that MUFG Corporate Markets cannot provide any financial, legal or tax advice and calls may be recorded and monitored for security and training purposes.

Scheme process

In accordance with Section 5 of Appendix 7 to the Takeover Code, Epwin will announce through a Regulatory Information Service key events in the Scheme process including the outcomes of the Meetings and the Court Hearing.

Unless otherwise consented to by the Court (if required) and the Panel, any modification or revision to the Scheme will be made no later than the date which is 14 days prior to the Meetings (or any later date to which such Meetings are adjourned).